HemaSphere (Jun 2022)

P991: IMPAIRMENT OF TCR SIGNALLING IN PATIENTS WITH MYELOFIBROSIS TREATED WITH RUXOLITINIB

  • P. Harrington,
  • R. Dillon,
  • D. Radia,
  • D. McLornan,
  • N. Curto-Garcia,
  • C. Woodley,
  • S. Asirvatham,
  • S. Kordasti,
  • C. Harrison,
  • H. de Lavallade

DOI
https://doi.org/10.1097/01.HS9.0000846832.56792.11
Journal volume & issue
Vol. 6
pp. 881 – 882

Abstract

Read online

No abstracts available.